Supplementary Table. Antiviral Type and Timing of Treatment/Prescription Among Children and Adolescents With Laboratory-Confirmed Influenza and Medically Attended Illness Who Received or Were Prescribed Antivirals—Two Multi-State Surveillance Networks, United States, 2023–24 Influenza Season

Details

• Alternative Title:
  Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications — United States, 2023–2024:Table1[@]Supplementary Table. Antiviral Type and Timing of Treatment/Prescription Among Children and Adolescents With Laboratory-Confirmed Influenza and Medically Attended Illness Who Received or Were Prescribed Antivirals—Two Multi-State Surveillance Networks, United States, 2023–24 Influenza Season
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.).
• Description:
  Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 45, November 14, 2024
• Subjects:
  Adolescent Antiviral Agents Child Disease Control Disease Notification Influenza Public Health Public Health Surveillance
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 45
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Genre:
  Tables ; Statistics
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  73
• Issue:
  45
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:f527d1ca3f72dc5f67f6983b4ec371ff55d1e77f0a779df20fc1458add9516210e563cacb3eddbd7ed76a3c79f938ea77a7530c7234f9cc66c21d684473db542
• Download URL:
  https://stacks.cdc.gov/view/cdc/168887/cdc_168887_DS1.pdf
• File Type:
  [PDF - 142.11 KB ]